Home » Stocks » TRXC

TransEnterix, Inc. (TRXC)

Stock Price: $0.477 USD 0.052 (12.33%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 47.70M
Revenue (ttm) 2.76M
Net Income (ttm) -59.96M
Shares Out 99.91M
EPS (ttm) -1.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $0.477
Previous Close $0.425
Change ($) 0.052
Change (%) 12.33%
Day's Open 0.425
Day's Range 0.424 - 0.501
Day's Volume 5,825,942
52-Week Range 0.280 - 2.700

More Stats

Market Cap 47.70M
Enterprise Value 29.39M
Earnings Date (est) Mar 2, 2021
Ex-Dividend Date n/a
Shares Outstanding 99.91M
Float 91.74M
EPS (basic) -1.38
EPS (diluted) -1.21
FCF / Share -0.33
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.67M
Short Ratio 2.14
Short % of Float 4.00%
Beta 2.42
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 17.31
PB Ratio 0.69
Revenue 2.76M
Operating Income -57.08M
Net Income -59.96M
Free Cash Flow -32.36M
Net Cash 18.30M
Net Cash / Share 0.18
Gross Margin -173.94%
Operating Margin -2,071.04%
Profit Margin -2,175.70%
FCF Margin -1,174.20%
ROA -44.58%
ROE -94.10%
ROIC -250.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 1
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$1.45*
Low
1.45
Current: $0.477
High
1.45
Target: 1.45
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue8.5324.107.111.52-0.401.432.12--
Revenue Growth-64.6%238.94%368.14%---71.98%-32.34%---
Gross Profit-12.207.930.380.45--0.69-3.38-2.31--
Operating Income-164-50.16-59.27-123-46.77-36.61-25.60-15.07-5.67-5.35
Net Income-154-61.78-145-120-46.95-37.65-28.36-15.43-5.76-5.30
Shares Outstanding17.7415.9411.448.636.124.520.980.080.430.34
Earnings Per Share-8.69-3.88-12.61-13.91-7.67-8.32-28.99-185.91-13.65-30.55
Operating Cash Flow-73.48-48.49-47.30-52.39-38.76-33.35-21.24-14.15-4.87-4.53
Capital Expenditures15.53-0.74-1.99-1.36-1.23-2.15-1.38-0.14-0.29-0.28
Free Cash Flow-57.96-49.23-49.29-53.75-39.99-35.50-22.61-14.28-5.16-4.81
Cash & Equivalents10.5773.4497.6134.5938.4535.0216.5810.180.303.03
Total Debt-28.9413.1712.9919.729.798.4810.002.520.05
Net Cash / Debt10.5744.5084.4321.6018.7325.238.100.18-2.232.98
Assets74.7823925017624913511717.560.993.69
Liabilities19.2470.7971.4058.3871.3313.3211.6911.172.990.27
Book Value55.54169179118177122105-68.61-2.003.42
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name TransEnterix, Inc.
Country United States
Employees 160
CEO Anthony Fernando

Stock Information

Ticker Symbol TRXC
Stock Exchange NYSE American
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSEAMERICAN: TRXC

Description

TransEnterix, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company's products include Senhance System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and other select countries. The company was founded in 2006 and is based in Morrisville, North Carolina.